share_log

Bath & Body Works To See More Comfort In Second Half Numbers With Further Improvement: Analysts

Bath & Body Works To See More Comfort In Second Half Numbers With Further Improvement: Analysts

分析師表示,隨著進一步改善,Bath & Body Works在下半年的數字將會更加安穩。
Benzinga ·  06/06 03:27

Bath & Body Works, Inc. (NYSE:BBWI) recently reported its first-quarter FY24 results, in which inventories increased 5.6% year over year to $814 million.

Bath & Body Works公司(NYSE:BBWI)最近報告了其2024財年第一季度業績,其庫存同比增長5.6%,達到8.14億美元。

Here's a glimpse into analysts' reactions to the company's quarterly performance:

以下是分析師對該公司季度業績的反應:

  • Goldman Sachs analyst Kate McShane reiterated a Buy rating with a price forecast of $60.
  • BMO Capital Market analyst Simeon Siegel reiterated the Outperform rating, raising the price forecast to $55 from $50.
  • JP Morgan analyst Matthew R. Boss reiterated a Neutral rating with a price forecast of $53.
  • BofA Securities analyst Lorraine Hutchinson reiterated Buy rating, with a price objective of $54.
  • 高盛的分析師凱特·麥克肖恩重申買入評級,目標價爲60美元。
  • BMO資本市場的分析師西蒙·西格爾重申跑贏大盤評級,並將目標價從50美元上調至55美元。
  • JP Morgan的分析師馬修·R·博斯重申中立評級,並給出53美元的目標價。
  • BofA證券的分析師Lorraine Hutchinson重申買入評級,目標價爲54美元。

Goldman Sachs: According to the analyst, the top line came in above expectations, driven by continued newness. However, category trends were mixed, with strength in body care.

高盛:據該分析師稱,總收入超出預期,這歸因於持續的新產品推出。然而,類別趨勢存在分歧,個別產品表現較好,如身體護理。

McShane reiterated the Buy rating even with a weighted guidance for the second half of the year, given the number of initiatives the company has for growth, including its robust pipeline of product ideas and newness and the rollout of category adjacencies.

即使公司下半年的加權指引可能不甚理想,麥克肖恩仍重申買入評級,原因在於公司迅猛增長的各項舉措,包括大量新產品和類別鄰近品類的推出。

BMO: Analyst Siegel highlighted questions surrounding the revenue decline the company would face as it laps its incredible pandemic strength.

BMO:分析師西格爾關注公司在逐漸逾越疫情造成的不可思議勢頭後,營業收入是否仍會下降。

However, the analyst said Bath & Body Works is progressing exactly as one would hope a turn would look, providing more comfort in 2H numbers and further improvement.

但該分析師認爲,Bath & Body Works公司的步履正是我們所期望的,爲2H的數據提供了更多的信心,並進一步改善了公司的表現。

This continues to suggest that the company is under-earning and its valuation trough should increase into the double-digit PE range.

這仍然表明公司存在低估,並且其市盈率將會增加到兩位數的區間。

JP Morgan: Analyst Matthew R. Boss highlighted the combination of normalizing same-store-sales relative to pre-pandemic, coupled with high-single-digit comp growth.

JP Morgan:分析師Matthew R. Boss認爲,相對於疫情前的同店銷售,公司現在正回歸正常增長,同時同店銷售及營業收入將保持高單數增長。

In addition, management confirmed May AURs tracking "on plan" for Flat AUR expectations.

此外,管理層確認五月份實際平均單價(AUR)與預期相符,達到預計的水平。

BofA Securities: Following the quarterly results, the analyst trimmed the FY24 EPS estimate by 3% to $3.24 but modeled no change to the FY25 estimate of $4.

BofA證券:在季度業績之後,分析師將人均每股收益(EPS)預期下調3%至3.24美元,但預計2025財年的EPS將不變,爲4美元。

Product newness is working, with body care growing LSD driven by men's, travel, lip, and Fine Fragrance Mist.

新產品的推出非常成功,身體護理系列以男性、旅行裝、口紅和優雅芳香噴霧爲驅動增長。

Fine Fragrance Mist was a test and will now roll out to the entire fleet in the second half, the analyst adds.

優雅芳香噴霧經過試驗,現在將在下半年推向整個零售渠道。

Continued growth in core categories and expansion in new adjacencies should drive positive total sales growth by the third quarter, Hutchinson adds.

Hutchinson補充道,核心類別的持續增長以及新鄰近類別的拓展應該會推動總的營收增長於第三季度實現正增長。

Price Action: BBWI shares are trading higher by 3.74% to $46.86 at last check Wednesday.

股價:BBWI股票上漲3.74%,報46.86美元。

Photo via Wikimedia Commons

照片通過Wikimedia Commons

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論